Skip to main content

Table 6 Sensitivity analyses comparing IJV versus SCV

From: Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies

Outcomes OR (95 % CI)
Base casea Using fixed-effects model RCTs includeda Non-randomized cohort studies includeda
TIVAD-related infections 0.71 (0.48–1.04) 0.70 (0.47–1.03) 0.47 (0.17–1.28) 0.76 (0.50–1.16)
Catheter-related thrombotic complications 0.76 (0.38–1.51) 0.91 (0.57–1.43) 0.90 (0.17–4.68) 0.56 (0.27–1.16)
Total major mechanical complications 0.38 (0.24–0.61) 0.36 (0.26–0.49) 0.30 (0.17–0.53) 0.44 (0.22–0.88)
Catheter dislocation 0.43 (0.22–0.84) 0.43 (0.23–0.83) NAb 0.40 (0.15–1.07)
Malfunction 0.42 (0.28–0.62) 0.42 (0.28–0.62) 0.28 (0.12–0.64) 0.47 (0.30–0.74)
Catheter fracture 0.47 (0.21–1.05) 0.38 (0.18–0.78) NAb 0.50 (0.15–1.61)
  1. Abbreviation: NA not applicable
  2. aRandom-effects model was used in these analyses
  3. bSensitivity analysis was not conducted because only one study was included